Fundraising Fox

Q BioMed

New York, US · Founded 2013 · Nevada corporation

Biotech

Founders & leadership

WS
William S. RosenstadtExecutive
DC
Denis CorinNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$7.6M disclosed across 6 of 7 rounds · 2016–2021

▶$500KraisedDec 2019 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • William S. RosenstadtExecutive Officer, Director
  • Denis CorinExecutive Officer, Director
Offering amount
$500K
Amount sold
$500K
First sale
Aug 2019
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1MraisedDec 2019 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • William S. RosenstadtExecutive Officer, Director
  • Denis CorinExecutive Officer, Director
Offering amount
$3M
Amount sold
$1M
First sale
Dec 2019
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1MraisedDec 2019 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • William S. RosenstadtExecutive Officer, Director
  • Denis CorinExecutive Officer, Director
Offering amount
$3M
Amount sold
$1M
First sale
Dec 2019
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$500KraisedDec 2019 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Denis CorinExecutive Officer, Director
  • William S. RosenstadtExecutive Officer, Director
Offering amount
$750K
Amount sold
$500K
First sale
Oct 2019
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.1MraisedAug 2017 · 18 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • William S. RosenstadtExecutive Officer, Director
  • Denis CorinExecutive Officer, Director
Offering amount
$3.1M
Amount sold
$3.1M
Sales commissions
$20.3K
Finders' fees
$102.1K
Placement agents
Brookline Capital Markets, a division of CIM Securities, LLC
First sale
Aug 2017
Incorporated
Corporation, Nevada, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedDec 2016 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • William S. RosenstadtExecutive Officer, Director
  • Denis CorinExecutive Officer, Director
Offering amount
$4M
Amount sold
$1.5M
Minimum investment
$1.5M
First sale
Nov 2016
Incorporated
Corporation, Nevada, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Q BioMed Inc. Provides Update to Shareholdersprnewswire.com · Jun 2023Q BioMed raises $2M with plans for uplisting on NASDAQ; updates on activity for coming monthsproactiveinvestors.com · Oct 2021Q Biomed Inc. Announces Funding to Technology Partner Mannin Research Inc. to Expand Product Pipelineprnewswire.com · Nov 2017

Frequently asked questions

How much funding has Q BioMed raised?
Q BioMed has disclosed $7.6M raised across 6 of its 7 known rounds.
Where is Q BioMed headquartered?
Q BioMed is headquartered in New York, US.